GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Astrana Health Inc (NAS:ASTH) » Definitions » Cash Flow from Financing

Astrana Health (Astrana Health) Cash Flow from Financing : $117 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Astrana Health Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2024, Astrana Health paid $0 Mil more to buy back shares than it received from issuing new shares. It received $106 Mil from issuing more debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $0 Mil paying cash dividends to shareholders. It received $0 Mil on other financial activities. In all, Astrana Health earned $106 Mil on financial activities for the three months ended in Mar. 2024.


Astrana Health Cash Flow from Financing Historical Data

The historical data trend for Astrana Health's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astrana Health Cash Flow from Financing Chart

Astrana Health Annual Data
Trend Jan14 Mar15 Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 163.33 -51.70 -47.75 -20.09 3.42

Astrana Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.10 -0.96 -0.51 11.99 106.35

Astrana Health Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Astrana Health's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

Astrana Health's Cash from Financing for the quarter that ended in Mar. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $117 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Astrana Health  (NAS:ASTH) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Astrana Health's issuance of stock for the three months ended in Mar. 2024 was $0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Astrana Health's repurchase of stock for the three months ended in Mar. 2024 was $0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Astrana Health's net issuance of debt for the three months ended in Mar. 2024 was $106 Mil. Astrana Health received $106 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Astrana Health's net issuance of preferred for the three months ended in Mar. 2024 was $0 Mil. Astrana Health paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Astrana Health's cash flow for dividends for the three months ended in Mar. 2024 was $-0 Mil. Astrana Health spent $0 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Astrana Health's other financing for the three months ended in Mar. 2024 was $0 Mil. Astrana Health received $0 Mil on other financial activities.


Astrana Health Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Astrana Health's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Astrana Health (Astrana Health) Business Description

Traded in Other Exchanges
Address
1668 S. Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Apollo Medical Holdings Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care in a cost-effective manner. It is focused on physicians providing high-quality medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.
Executives
Chandan Basho officer: See Remarks 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
John Vong officer: SVP-Chief Accounting Officer 4288 BIRCHWOOD AVENUE, SEAL BEACH CA 90740
Linda Marsh director 100 N. STONEMAN AVE., ROOM 200, ALHAMBRA CA 91801
Allied Physicians Of California, A Profession Medical Corp 10 percent owner 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Weili Dai, director 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
J. Lorraine Estradas director 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
David Schmidt director 700 N. BRAND BLVD, SUITE 220, GLENDALE CA 91203
Albert Waichow Young officer: Chief Administrative Officer 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Adrian Vazquez officer: Chief Medical Officer C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
Thomas S. Lam director, officer: President and Co-CEO 1668 GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Kenneth T. Sim director, officer: Executive Chairman and Co-CEO 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Brandon Sim director, officer: See Remarks C/O APOLLO MEDICAL HOLDINGS, INC., 1668 S. GARFIELD AVENUE, 3RD FLOOR, ALHAMBRA CA 91801
Eric Chin officer: Chief Financial Officer 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Michael F. Eng director 712 BATAAN PLACE, MONTEREY PARK CA 91755
Hing Ang officer: Chief Operating Officer 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801